FOLLICULAR T-CELL LYMPHOMA

Clinical trials for FOLLICULAR T-CELL LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new FOLLICULAR T-CELL LYMPHOMA trials appear

Sign up with your email to follow new studies for FOLLICULAR T-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

New hope for Tough-to-Treat blood cancer? trial tests adding drugs to standard chemo

Disease control Terminated

This study aims to see if adding one of two new drugs (duvelisib or CC-486) to a standard chemotherapy regimen works better for treating newly diagnosed peripheral T-cell lymphoma, a rare and aggressive blood cancer. It will compare the complete remission rates and side effects b…

Matched conditions: FOLLICULAR T-CELL LYMPHOMA

Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control

Last updated Mar 31, 2026 12:22 UTC

FOLLICULAR T-CELL LYMPHOMA

Get alerted when new FOLLICULAR T-CELL LYMPHOMA trials appear

New hope for Tough-to-Treat blood cancer? trial tests adding drugs to standard chemo